|
🐢
|
Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain*
13 auth.
D. Moechars,
I. Dewachter,
K. Lorent,
D. Reversé,
V. Baekelandt,
A. Naidu,
I. Tesseur,
K. Spittaels,
C. V. Haute,
F. Checler,
...
E. Godaux,
B. Cordell,
F. van Leuven
|
9 |
1999 |
9
🐢
|
|
🐜
|
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.
15 auth.
R. Postina,
Anja Schroeder,
I. Dewachter,
J. Bohl,
U. Schmitt,
E. Kojro,
Claudia Prinzen,
K. Endres,
C. Hiemke,
M. Blessing,
...
Pascaline Flamez,
Antoine Dequenne,
E. Godaux,
F. van Leuven,
F. Fahrenholz
|
9 |
2004 |
9
🐜
|
|
🐜
|
Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae
9 auth.
R. Osborn,
G. De Samblanx,
K. Thevissen,
I. Goderis,
S. Torrekens,
F. van Leuven,
...
S. Attenborough,
S. Rees,
W. Broekaert
|
8 |
1995 |
8
🐜
|
|
🐜
|
Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes
10 auth.
Marta Pajares,
Natalia Jiménez-Moreno,
Á. J. García-Yagüe,
M. Escoll,
M. L. de Ceballos,
F. van Leuven,
...
A. Rábano,
Masayuki Yamamoto,
A. I. Rojo,
A. Cuadrado
|
8 |
2016 |
8
🐜
|
|
🐜
|
Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.
12 auth.
R. Etcheberrigaray,
M. Tan,
I. Dewachter,
Cuno Kuiperi,
I. van der Auwera,
S. Wera,
...
L. Qiao,
B. Bank,
T. Nelson,
A. Kozikowski,
F. van Leuven,
D. Alkon
|
8 |
2004 |
8
🐜
|
|
🐜
|
Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis
13 auth.
P. Rada,
A. I. Rojo,
N. Evrard-Todeschi,
Nadia G. Innamorato,
Axelle Cotte,
Tomasz Jaworski,
J. C. Tobón-Velasco,
H. Devijver,
M. García-Mayoral,
F. van Leuven,
...
J. Hayes,
G. Bertho,
A. Cuadrado
|
8 |
2012 |
8
🐜
|
|
🐜
|
Nonsteroidal Anti-Inflammatory Drugs and Peroxisome Proliferator-Activated Receptor-γ Agonists Modulate Immunostimulated Processing of Amyloid Precursor Protein through Regulation of β-Secretase
7 auth.
M. Sastre,
I. Dewachter,
G. Landreth,
T. Willson,
T. Klockgether,
F. van Leuven,
...
M. Heneka
|
8 |
2003 |
8
🐜
|
|
🐬
|
A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease
I. van der Auwera,
S. Wera,
F. van Leuven,
S. Henderson
|
8 |
2005 |
8
🐬
|
|
🐜
|
Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding.
14 auth.
T. Gevaert,
J. Vriens,
A. Segal,
W. Everaerts,
T. Roskams,
K. Talavera,
G. Owsianik,
W. Liedtke,
D. Daelemans,
I. Dewachter,
...
F. van Leuven,
T. Voets,
D. de Ridder,
B. Nilius
|
8 |
2007 |
8
🐜
|
|
🐢
|
Phosphorylation, Subcellular Localization, and Membrane Orientation of the Alzheimer's Disease-associated Presenilins*
11 auth.
B. de Strooper,
M. Beullens,
B. Contreras,
L. Lévesque,
K. Craessaerts,
B. Cordell,
...
D. Moechars,
M. Bollen,
P. Fraser,
P. S. St George-Hyslop,
F. van Leuven
|
8 |
1997 |
8
🐢
|
|
🐢
|
Glycogen Synthase Kinase-3β Phosphorylates Protein Tau and Rescues the Axonopathy in the Central Nervous System of Human Four-repeat Tau Transgenic Mice*
15 auth.
K. Spittaels,
C. Van den Haute,
J. van Dorpe,
H. Geerts,
M. Mercken,
K. Bruynseels,
R. Lasrado,
K. Vandezande,
I. Laenen,
T. Boon,
...
J. Van Lint,
J. Vandenheede,
D. Moechars,
R. Loos,
F. van Leuven
|
8 |
2000 |
8
🐢
|
|
🐢
|
Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.
7 auth.
D. Terwel,
David Muyllaert,
I. Dewachter,
P. Borghgraef,
S. Croes,
H. Devijver,
...
F. van Leuven
|
8 |
2008 |
8
🐢
|
